Overview:

TechNavio’s analysts forecast that the Global Implantable Cardioverter Defibrillator (ICD) will reach $7.8 billion in 2014. One of the key factors contributing to this market growth is the positive effects of remote monitoring of patients. The ICD market has also been witnessing mergers and acquisition between vendors. However the saturation of ICD market could be a challenge to the growth of this market.

Key vendors dominating this market space include Medtronic Inc, St.Jude Medical Inc, Boston Scientific Corporation, Sorin Group, and Biotronik Inc.

TechNavio’s Global Implantable Cardioverter Defibrillator (ICD) 2010-2014 has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on Americas, EMEA and APAC and covers the market of Global Implantable Cardioverter Defibrillator (ICD).

Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. Introduction
03. Market Landscape
04. Vendor Landscape
05. Market Growth Drivers
06. Market Challenges
07. Market Trends
08. Key Vendor Analysis
08.1 Medtronic Inc
08.2 St. Jude Medical Inc
08.3 Boston Scientific Corporation
08.4 Sorin Group
08.5 Biotronik Inc
09. Other Reports in this Series


List of Exhibits


Exhibit 1: Overall Global Implantable Cardioverter Defibrillator Market 2010-2014 ($ billion)
Exhibit 2: Global Implantable Cardioverter Defibrillator by Geography (2010)
Exhibit 3: Market Share of Key Global Implantable Cardioverter Defibrillator - 2010